Research ArticleExperimental Studies

The Predominant CD44 Splice Variant in Prostate Cancer Binds Fibronectin, and Calcitonin Stimulates its Expression

KENNETH A. ICZKOWSKI, A. LEVI OMARA-OPYENE and GIRISH V. SHAH
Anticancer Research July 2006, 26 (4B) 2863-2872;

Article Information

vol. 26 no. 4B 2863-2872
PMID 
16886606
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received April 28, 2006
  • Accepted May 8, 2006
  • Published online July 1, 2006.
Copyright & Usage 
Copyright© 2006 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. KENNETH A. ICZKOWSKI1,2,
  2. A. LEVI OMARA-OPYENE1 and
  3. GIRISH V. SHAH3
  1. 1Department of Pathology, Immunology, and Laboratory Medicine, The University of Florida
  2. 2Department of Pathology, Immunology, and Laboratory Medicine, Veterans Administration Medical Center, Gainesville, FL
  3. 3Department of Pharmaceutical Sciences, University of Louisiana, Monroe, LA, U.S.A.
  1. Correspondence to: Kenneth A. Iczkowski, MD, Pathology and Laboratory Medicine Service (113), VA Medical Center, 1601 S.W. Archer Road, Gainesville, FL 32608-1197, U.S.A. Tel: (352) 376-1611/4522, Fax: (352) 379-4023, e-mail: iczkoka{at}pathology.ufl.edu

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
The Predominant CD44 Splice Variant in Prostate Cancer Binds Fibronectin, and Calcitonin Stimulates its Expression
KENNETH A. ICZKOWSKI, A. LEVI OMARA-OPYENE, GIRISH V. SHAH
Anticancer Research Jul 2006, 26 (4B) 2863-2872;
Twitter logo Facebook logo Mendeley logo

Jump to section